Melperone Market

Melperone is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. Melperone has been used for a span of greater than 30 years in the European Union?. It has been well established in the treatment of confusion, anxiety, restlessness (particularly in the elderly) and schizophrenia as It is known to be well-tolerated with an excellent safety profile.?
Melperone Market contains market size and forecasts of Melperone in global, including the following market information:
Global Melperone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Melperone Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Melperone companies in 2021 (%)
The global Melperone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Melperone include Novartis, ABZ-Pharma, Nidda Healthcare, Teva, Aristo Pharma, Dr. Reddy's Laboratories and Neuraxpharm Arzneimittel, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Melperone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melperone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Melperone Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Melperone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Melperone Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Global Melperone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Melperone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melperone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Melperone revenues share in global market, 2021 (%)
Key companies Melperone sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Melperone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
ABZ-Pharma
Nidda Healthcare
Teva
Aristo Pharma
Dr. Reddy's Laboratories
Neuraxpharm Arzneimittel